Had the share price been above (I believe) 1.75, Terren the tolite paper Peizer could have exercised the warrants and collected the shares which would have increased overall share count which would have diluted our shares, which in theory should make the price go down. Since the price stayed under 1.75 Terren the Tolite Paper Peizer couldn't exercise the warrants and therefore the warrants expired worthless. Poof they are gone and no worries about adding those extra shares from the warrants (I believe 2.5m) to the shares outstanding.
Hope that makes sense.
Still expecting the share price to move up nicely from here.
Pull from Ihub board:
September 29th 1 250,000 at 3.36 a share and September 29th 1 000 000 at 2.59 a share Crede Tranche 1A and 1B warrant
Lol your name should be coming_from_2months_ago. First of all I own 15.5k SPHS but a buyout after iffy Phase 3 BPH and p2a for prostate cancer was only 18 men. Buyout will come with good P2B results for prostate cancer. Perhaps a partner will come in the coming months, since oppeinheimer is still engaged. Hey if it's a buyout I'll come back and hug you.
There is more than 20m shares outstanding now since dilution. Probably closer to 30m now with the dilution plus the warrants.
Buy if you can afford a risk and have a year time horizon. I will admit if P2B does well, which they are increasing the dosage 200x compared to P2a, then SPHS WILL BE HUGE.
XXII is WAY more of a sure bet on a buyout or big increase in valuation with a shorter time horizon IMO.
I also have to wonder if the whole X22 and reaching out to Pharma Companies is just a front for leverage. Pharma is one of the main contributors to anti smoking campaigns. Not a friend of Big T. Is XXII really playing both sides of the fence? Me thinks not. Me thinks side is picked. All my opinion though.
Haha I mean like I said it's just a hunch. I'm skeptical we can get a positive favoring for the Brand B proof of concept. I would think a smaller, stubbier cig would be beneficial but I can't see something like a Red Sun as being something the FDA could get behind. Personally I think BAT is more interested in the high nicotine for the heat not burn, but I think they could do things with the VLN (Brand A) and LTN (Brand B) as well. Just good technology for them to have.
I personally just can't imagine it's XXII that's putting on the brakes here. Not only that, but why would a company roll out a brand new cig design, of which they don't know if it will be accepted, into two different countries? Debut in one country that way if it fails or something goes wrong, your not on the hook with 100 more retailers (originally France was to be 100 retailers if memory serves).
I think BAT commercializes with a Brand A acceptance by FDA. A Brand B positive POC will only solidify that for me. If that Brand B POC is positive, LOOKOUT. That will be huge and a surprise to me as well as others I think. Both Henry and Joe said in the WF/Bonnie Herzog interview that they believe Brand B is the real money maker.
I don't entirely rule out a buyout after a Brand A acceptance, but I don't think it's enough for a BO. But it could be just to shelve it ASAP by Big T.
Don't think it will move the price in a big way. Should already be baked in...for the 4th time now.... :)
To be honest I wonder if we will even see France get its debut. It's strange that the debut with the new filters keep getting delayed. I personally think it's on purpose. It will be interesting to see how the rest of this year plays out.
No New China news
No New Magic distribution
Nothing on X22
Brand B proof of concept in December
Why? I have a hunch but it's a big hunch/guess.
To inform investors and to generate interest from potential research and commercial partners, Botanical Genetic has today launched a new website at www.botanicalgenetics.com. The new website details Botanical Genetics’ strategy, partners, and projects in the rapidly evolving cannabis space. The Company’s primary initiatives include:
1) Botanical Genetics is developing new technologies to make cannabis plants more amenable to genetic enhancement and improvement.
2) Botanical Genetics is developing new methods for the manipulation of cannabis plants to result in unique cannabinoid profiles in proprietary strains of the plant.
3) Together with its industry partners, Botanical Genetics is modifying cannabis plants to produce altered profiles of the major cannabinoids, leading both to new medical marijuana products and to new industrial hemp varieties.
4) As previously announced, Botanical Genetics is developing the means to produce cannabinoids in tobacco – a plant species that shows great promise as a biofactory for the production of cannabinoids.
5) Botanical Genetics is actively involved in several state-based industrial hemp pilot programs to develop and breed improved varieties of industrial hemp that are specifically optimized to grow in the climates of particular U.S. states.
In conducting the Company’s legal cannabis research, Botanical Genetics operates its own laboratories in New York, sponsors research activities in Vancouver, Canada, and partners with universities, commercial laboratories, and hemp/cannabis growers in an increasing number of U.S. states.
“We are the only company in the United States with the freedom to use all of the enzyme genes in the cannabis plant that lead to THC, CBD, CBC, and other important cannabinoids,” explained Henry Sicignano, III, President and CEO of 22nd Century. “I am proud that our unique – and growing – intellectual property portfolio puts 22nd Century at the forefront of cannabis biotechnology.”
Acknowledging 22nd Century’s growing influence in the cannabis technology arena, Dr. Paul Rushton, Vice President for Plant Biotechnology, and Thomas James, Vice President and General Counsel of 22nd Century, have been appointed to the advisory committee of the “iHemp Platform.” The iHemp Platform is a cooperative association of progressive hemp farmers, industry experts and university leaders who are working together on the successful implementation of state and regional industrial hemp pilot programs.
Dr. Rushton explained, “We have decisive plans to make Botanical Genetics the U.S. leader in cannabis biotechnology. The medical marijuana and industrial hemp markets are projected to be worth billions of dollars in the very near term and we intend to be a major player in these developing industries.”
Just had to wait till the rats and snakes ran/slithered away.
Part of me does wish car boy would return. Only because he kept bashing me on SPHS and I turned around a $100k profit in 3 months.
Should turn another $50k-$100k on this next run up into EOY I think...
Considering SM didn't get theirs in 365 days that makes sense. The extremities of advertising would be the only thing I can think of for such a delay in a decision. It's a 0% nicotine cig. Politics or not it's absurd.
That was not what I heard from Henry at all. Decision is expected to be made, per the FDAs own guidelines, by Jan 1 2017. I believe Henry told someone on the call to expect it to be the full 365 days before a decision is made. I could be wrong though. Will have to check out the transcript
Remember FDA funded a lot of the Brand A (Very Low Nicotine) cigarette studies that XXII used in their submission...back to the FDA. Lol. That's the best. The FDA basically funded our research so we could submit our modified risk application. Does anyone really think the FDA would throw millions of dollars at these studies, of which all have positive conclusions, only to turn around and say "no sorry there's no place in the market for a non addictive cigarette"? Would the FDA turn down XXIIs submission after the WHO, NIDA, NIH, & CDC all sung Brand A/VLN Cig's praises? NOWAY I say.
If the FDA is worried about the 1000 new 18 year olds every day that try cigs, then they will accept Brand A and get it out there so these young kids can try a non addictive product to see if they even enjoy smoking first. GIVE THEM THE OPTION FDA.
What about the people who have tried everything to quit? Don't they deserve one more option?
What about the people who did successfully walk away from cigs, but then a little stress has them itching to draw that smoke and flick that cig. Don't these strong people deserve a non addictive option?
What about the people who are only smokers on the weekends while drinking? Do they deserve to not be able to enjoy a non addictive cig so when they go to work Monday morning they won't have that craving to step outside and take a smoke break?
Do I need to go on? It's about providing people with options so THEY can choose the direct path. You have the warnings and public drilling it into young kids heads that smoking is bad. Smoking is a personal choice at this point. A VLN is just one more CHOICE a consumer can make before deciding if they want to smoke or not.
I don't believe VLN is any silver bullet that will make everyone quit, but it deserves to be out on the market and there are many niche situations where people could choose a non addictive cig to smoke.
By end of year. Then a license deal. Now is a good time to get in. Price won't be around here in October in my opinion. More like 1.25-1.40 level come October. All my opinion...
CEO stated patents alone were worth $200m. i have started to wonder why the constant delay of rolling out magic. Do they even want to roll it out? Doesn't seem like it!!!
Look into BATs company "nicoventures" and their goal/mission. Does this not sound like an entity that would be interested in Brand A or X22?
Now look at XXII high nicotine tech and the Heat Not Burn market. BAT has been pretty silent about their Heat Not Burn technology/product, however Phil Morris has been pretty loud about theirs however a couple of the articles I read about IQOS says that it still lacks that "throat hit" that is similar to a cig.
If you do some research on what causes that "throat hit" a lot of it has to do with nicotine content. I think BAT could benefit greatly from utilizing XXII high nicotine AND low nicotine.
A positive Brand B proof of concept with the FDA in December would only add more fuel to my fire that we are going to be bought by BAT.
All one has to do is look for a "_" in their alias to know. They make so many that they can't remember which is which so they have to make a marking so they know. They are on twits too
Rather humerus you're writing this now but when I wrote something similar back in May you gave me #$%$ for it. I just stop by every now and again to check if there are any real investors on this board or if it's the same person via multiple aliases (bull and bear) talking back and forth between them self. It would appear that you are surrounded.